Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

General Anaesthesia

Phase 3Small molecule

AAssistance Publique - Hôpitaux de Paris

1

Indications

3

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

General AnaesthesiaNot yet recruiting

General AnaesthesiaPhase 3

Not yet recruiting

Timeline

Expected Milestones

Q4 2029

Post-ApprovalNot yet recruiting

General Anaesthesia

NCT07334132

Clinical

Trials by Indication[1]

General Anaesthesia1 trial

General Anaesthesia vs Spinal Anaesthesia: Patient Outcomes and Success in Outpatient Primary Total Knee and Hip Arthroplasty

Not yet recruiting·RRegion Örebro County·Phase 4·NCT07334132·600 enrolled

Sedation1 trial

Safety Study of Colonoscopy Under Sedation

Terminated·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT00930358·220 enrolled

Osteoarthritis, Hip1 trial

Randomized Trial on Spinal Anaesthesia vs. General Anaesthesia (SAGA) on Recovery After Total Hip, Total Knee, and Unicompartmental Knee Arthroplasty

Completed·AAnders Troelsen·Approved·NCT05706844·222 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for General Anaesthesia. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — General Anaesthesia compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for General Anaesthesia. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Assistance Publique - Hôpitaux de Paris company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAssistance Publique - Hôpitaux de Paris

Related News